koi fish meaning

Shares of Hoya Capital Housing ETF ( NYSEARCA:HOMZ – Get Free Report ) fell 1.3% during trading on Friday . The stock traded as low as $45.29 and last traded at $45.34. 4,001 shares were traded during trading, an increase of 45% from the average session volume of 2,756 shares. The stock had previously closed at $45.94. Hoya Capital Housing ETF Price Performance The stock has a market capitalization of $44.21 million, a P/E ratio of 13.11 and a beta of 1.26. The stock’s fifty day moving average is $48.71 and its two-hundred day moving average is $47.55. About Hoya Capital Housing ETF ( Get Free Report ) The Hoya Capital Housing ETF (HOMZ) is an exchange-traded fund that is based on the Hoya Capital Housing 100 index. The fund tracks a tier-weighted index of 100 equities representing the US residential housing industry. HOMZ was launched on Mar 20, 2019 and is managed by Hoya. Featured Articles Receive News & Ratings for Hoya Capital Housing ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya Capital Housing ETF and related companies with MarketBeat.com's FREE daily email newsletter .( ) is a digital healthcare company focusing on developing technology and services that could aid healthcare professionals in delivering positive patient outcomes. The company has witnessed healthy buying this year, with its stock price rising by 84.4%. Its solid quarterly performances and continued acquisitions have boosted its financials. Let’s assess whether WELL Health offers buying opportunities at these levels by looking at its third-quarter earnings and growth prospects. WELL Health’s third-quarter performance Last month, WELL Health reported an impressive third-quarter performance, with its growing by 27% to $251.7 million. Organic growth of 23% and acquisitions over the last four quarters drove its sales, while the divestments offset some of the growth. It had around 1.48 million patient visits and 2.24 patient interactions during the quarter, representing a year-over-year growth of 41% across both metrics. Amid the topline growth, its gross profits grew by 19%. However, its adjusted gross margin contracted by 150 basis points to 44.6% amid increased contributions from lower-margin recruiting revenue from the acquisition of CarePlus. The digital healthcare company’s adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) grew 16% to $32.7 million. However, the adjusted EBITDA to WELL’s shareholders rose by 10% to $25.1 million. Its adjusted net income stood at $13 million, slightly improving from $12.9 million in the previous year’s quarter. The company generated $16.2 million of adjusted free cash flow during the quarter, supported by its comprehensive cost-cutting program, which it implemented earlier this year. Now, let’s look at its growth prospects. WELL Health’s growth prospects Given their accessibility, cost-effectiveness, and convenience, more people are adopting digital healthcare services. Technological advancements and improving internet penetration have also contributed to the rising popularity of virtual services, thus expanding the addressable market for WELL Health. Meanwhile, the company continues to invest in advancing AI (artificial intelligence)-powered tech enablement for care providers, which could strengthen its position in the digital healthcare sector. The company’s acquisition pipeline looks solid, with 17 signed LOIs (letters of intent) and definitive agreements. Also, the company’s cost-cutting program would continue to improve its . Moreover, WELL Health has rebranded its subsidiary WELL Provider Solutions Group as WELLSTAR Technologies. This pure-play software-as-a-service (SaaS) technology company offers high-quality technology and services to around 37,000 healthcare providers to improve patient care. The company is also working on spinning out WELLSTAR, thus providing investors with an attractive investment opportunity in healthcare technology SaaS. It expects to complete the spinoff by the end of next year. WELLSTAR recently acquired two healthcare-focused technology companies, which could contribute $15 million in annualized revenue, thus raising its 2025 pro forma revenue to $70 million. Also, its gross margins could remain above 80% while its EBITDA margin would be around 20%. Considering all these factors, I believe WELL Health’s growth prospects look healthy. Investors’ takeaway Despite the substantial increase in its stock price, WELL Health’s valuation looks attractive. Its next-12-month and NTM multiples stand at 1.6 and 24.2, respectively. Given its solid growth prospects, improving profitability, and attractive valuation, I expect WELL Health to deliver superior returns over the next three years.

Phillies add depth to bullpen with 1-year deal for reliever Joe RossGap raises guidance ahead of holidays after storms, warm weather slowed sales

Macron calls Haitian officials 'total morons' over PM sackingWATCH: President Jimmy Carter surprised a family at their home in 1979

Prime Minister Narendra Modi on Saturday lauded the power of 'Nari Shakti' in shaping the Constitution and made a strong pitch for 'united Bharat' in realising the country's dreams in the twenty-first century. Joining the two-day debate on the Constitution, commemorating the 75th year of its adoption, PM Modi said that today, the country is being recognised and celebrated across the world as the 'Mother of Democracy'. "Nari Shakti played a crucial role in shaping and empowering the Constitution. There were 15 women members in the Constituent Assembly, who left their stamp on the sacred book. This is a matter of pride for us," PM Modi said. He further said that his government has focused heavily on women empowerment. "We have shifted focus from women-centric to women-led development. We cleared the Naari Shakti Adhiniyam Vandan to ensure active participation of women in the democracy. Today, women are breaking social barriers and making forays into every sector," PM Modi said in the concluding address in Lok Sabha. Making a strong pitch for 'unity', PM Modi called upon everyone including the Opposition parties to come together and contribute in achieving the shared dreams of the twenty-first century. "It's time for everyone to celebrate the unity in diversity and not get divided by some political motives," the Prime Minister said in the Lower House. The Prime Minister then counted several initiatives of his government and how this was focused on achieving one unified approach in making policies. "Article 370 was a major obstacle in India's unity and hence it was buried under the earth. Goods and Services Tax (GST) played a vital role in ensuring economic unity - one nation, one tax is taking this idea forward," he stated. PM Modi further said that his government strongly pushed for 'One nation, one ration card' to facilitate equitable treatment of every citizen across the country. "Under One nation- one health card i.e. Ayushman Bharat card, any Indian living in any part of the country can avail the same medical benefits under the scheme. One nation, one grid initiative has driven out darkness from urban centres as well as villages," PM Modi said. Laying emphasis on the government's focus on the digital economy, PM Modi said that democratising technology has ensured that the benefits of government schemes percolate down to remote locations without any discrimination. (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.) Featured Video Of The Day Top Actors Meet 'Pushpa 2' Star Allu Arjun After Release From Jail PM Modi PM Modi Constitution Debate pm modi lok sabha speech In Message Of Unity, PM Modi Spotlights Education In Regional Language In Parliament Speech "1 Family...": PM's Multi-Generational Attack On Congress Over Constitution PM Modi To Speak On Constitution, Day After Priyanka Gandhi's 'Sanghvidhaan' Jibe: Top Points "1 Family...": PM's Multi-Generational Attack On Congress Over Constitution Suchir Balaji, OpenAI Whistleblower, Found Dead At US Apartment, Musk Reacts Bihar Teacher Kidnapped On Way To School, Forced To Marry Woman At Gunpoint Kejriwal May Face Off Against Former Chief Ministers Sons From Home Turf CPI(M) Lifts Suspension Of Bengal Party Leader Accused Of Sexual Harassment Rajasthan Public Service Commission Hiring For 575 Professor Positions Track Latest News Live on NDTV.com and get news updates from India and around the world . MORE Trending News "1 Family...": PM's Multi-Generational Attack On Congress Over Constitution Vishy Anand Responds As Ex-World Champion Criticises Gukesh's Title Win Suchir Balaji, OpenAI Whistleblower, Found Dead At US Apartment, Musk Reacts Bihar Teacher Kidnapped On Way To School, Forced To Marry Woman At Gunpoint What Techie Suchir Balaji Said About OpenAI Before He Was Found Dead " Nahi Ho Raha... ": Bumrah's Frustration Caught On Stump Mic During 3rd Test Ex-Pak Star's 'IPL' Dig As Gillespie Resigns As Coach: "Just Make CVs..." PM Modi Replies To Debate On Constitution: Top 10 Quotes Kambli Responds After Kapil Dev Offers To Help Him: "Have No Hesitation..." "Once They Tasted Blood, They...": PM Attacks Congress In Parliament Samantha's Emotional Note After Allu Arjun's Reunion With Wife And Kids Top Stars, Unsold At IPL Auction, Unlikely To Play In PSL. Reason Is... "Live-In Partner's Taunts...": Unemployed Engineer Dies By Suicide In Noida Vikrant Massey Shares The Real Reason Behind Taking A Break From Acting Rahul Gandhi Draws 'Constitution vs Manusmriti' Parallel In Parliament Two Indian Delicacies Top List Of World's "Best Vegetable Dishes" Kartik Urges Saif-Kareena To Show Bhool Bhulaiyaa 3 To Their Kids IND vs AUS 3rd Test Day 2 Forecast: Brisbane Under 'Alert'. The Reason Is... Gujarat Man Chops Off Own Fingers To Avoid Working As Computer Operator PM Modi Attacks Congress Over Emergency During Constitution DebateRussia has a stock of powerful new missiles “ready to be used”, President Vladimir Putin has said, a day after his country fired a new ballistic missile at the Ukrainian city of Dnipro. In an unscheduled TV address, the Russian leader said the Oreshnik missile could not be intercepted and promised to carry out more tests, including in “combat conditions”. Russia’s use of the Oreshnik capped a week of escalation in the war that also saw Ukraine fire US and British missiles into Russia for the first time. Ukrainian President Volodymyr Zelensky called for world leaders to give a “serious response” so that Putin “feels the real consequences of his actions”. His country was asking Western partners for updated air defence systems, he added. According to news agency Interfax-Ukraine, Kyiv is seeking to obtain the US Terminal High Altitude Area Defense (THAAD), or to upgrade its Patriot anti-ballistic missile defence systems. In Friday’s address Putin said the Oreshnik hypersonic missiles flew at 10 times the speed of sound and ordered them to be put into production. He had earlier said that use of the missile was a response to Ukraine’s use of Storm Shadow and Atacms missiles. Thursday’s strike on Dnipro was described as unusual by eyewitnesses and triggered explosions which went on for three hours. The attack included a strike by a missile so powerful that in the aftermath Ukrainian officials said it resembled an intercontinental ballistic missile (ICBM). Justin Crump, CEO and founder of the risk advisory company Sibylline, told the BBC that Moscow likely used the strike as a warning, noting that the missile – which is faster and more advanced that others in its arsenal – has the capacity to seriously challenge Ukraine’s air defences. This week’s escalation has also prompted several warnings from other world leaders about the direction of the war between Russia and Ukraine. Polish Prime Minister Donald Tusk said the war was entering a decisive stage – with a real risk of global conflict. Hungarian Prime Minister Viktor Orban meanwhile said the West should take Vladimir Putin’s warnings “at face value” because Russia “bases its policies primarily on military power”. – BBC

Viewers of the BBC series Strike were left scratching their heads as the latest episode aired. The show, based on J.K. Rowling's novel The Ink Black Heart, penned under her pseudonym Robert Galbraith, follows Cormoran Strike as he investigates crimes. This series centres around the shocking murder of a cult YouTube cartoon writer, who had confided in Robin about being harassed and threatened by someone she believed was the anonymous creator of an unofficial spin-off game. As the latest episode unfolded, fans took to social media to share their thoughts. Some expressed confusion, with one fan tweeting: "So many names. I've totally lost track of who everyone is! #Strike," while another added: "#strike I'm lost with this storyline." A third viewer shared: "#strike bbc1 #TheInkBlackHeart Can't say I'm really understanding what this current Strike series is all about, not being into gaming or reading comics. Good acting throughout, no foul language but the storyline is for youngsters, presumably." However, not all viewers were perplexed, with some praising the series as "brilliant". One wrote: "#Strike @BBCOne Loving the latest series #TheInkBlackHeart Amazing as always. Brilliant cast and great storyline," while another chimed in: "Another great season of Strike. Tom Burke and Holliday Grainger have great chemistry. This season was definitely different from the rest, but the atmosphere and style were still quality. 10/10 series. #TheInkBlackHeart #Strike." A third viewer pleaded: "Could you drop 4 more i really dont want to wait another 2 years #Strike #TheInkBlackHeart," while a fourth enthused: "Every case ends with each season of Strike but the romantic intrigue just keeps intriguing. And I'm drowning in it. Help!" For many fans, the highlight of the show is the blossoming romance between Cormoran and Robin. Speaking about their on-screen relationship, actress Holliday Grainger revealed: "Their relationship is so complicated and there's a real fear of stepping over the line and there being a sense of no return. "It's written so well in the book, the breakdown of thoughts Robin has, of not knowing if he's going to regret it in the morning, if he's drunk a bit too much, or if this is not the right thing for him, and what it would mean for their business. It's only afterwards that she's like, 'Oh, that could have been something, maybe I was overthinking it.'" She added: "That moment makes her realise how she feels towards him properly for the first time, I think. But in that moment there's also fear of rejection, and of losing what they have, which is friendship. Robin has very few close friends, which is a big element." *Strike airs on BBC One and BBC iPlayer.CLEMSON — On Senior Day, Clemson defensive tackle Payton Page made a play that only the senior version of himself could make. Page, knocked off track by the shutdowns of the COVID-19 pandemic, was nearly 400 pounds when he arrived to Clemson as a freshman. That Page wouldn't have gotten very far after picking off Citadel quarterback Johnathan Bennett on Nov. 23 at Memorial Stadium. But this Page, down to 310 pounds, had just enough juice in his legs to sprint 57 yards to the end zone in the Tigers' 51-14 win over the Bulldogs. Clemson was able get another defender, linebacker Barrett Carter — who was also a running back in high school — into the end zone late on a four-yard rush, as well. There were unexpected scores, but the Tigers (9-2) mostly did what was expected versus an FCS squad. Clemson's offensive players scored at will, too, gaining some rhythm ahead of the regular-season finale with South Carolina. Defensively, there were a few missed assignments, allowing The Citadel to rack up 387 yards, including a season-high 288 rushing. That left something to be desired. But the Tigers' final memory in Death Valley in 2024 — and arguably the most important — will come in a week's time. A rivalry matchup with the Gamecocks awaits. The maturation of ‘Coach V’: Clemson's Tyler Venables takes after dad but remains his own person Clemson's offense has been up and down in recent weeks, but the Tigers operated with an ease expected versus an FCS opponent. They scored touchdowns on their first five possessions, including touchdowns of 30 yards (to Antonio Williams), 55 yards (to Bryant Wesco Jr.) and 70 yards (a rush by Jay Haynes). Cade Klubnik took a seat in the third quarter, finishing with 198 yards and three touchdowns on 12-of-16 passing. Clemson didn't have to overuse senior running back Phil Mafah, who had three carries for 14 yards. The Tigers didn't have to use offensive lineman Tristan Leigh or Marcus Tate, either. Leigh, the left tackle, wasn't in uniform for the game. Tate was dressed, but he didn't need to play. As expected, the Tigers were able to get some younger players on the field, and the redshirt freshman Haynes was probably the biggest star. He finished with 118 yards and two scores on just five carries. Hamilton: Top of rankings keep jammin' as college football show rolls on It's not like Clemson was the only Power 4 schools getting run on by a lesser foe. Georgia was outgained by UMass, 226-208, on the ground on Saturday. But allowing The Citadel to gain a season-high total on the ground, in Death Valley, was alarming for a Tigers' defense has been susceptible to the big play most of the season. The Citadel had a half-dozen runs of 10-plus yards in the first half, including a gash of 50 yards by running back Johnny Crawford III. The final total was exacerbated by Clemson pulling its starters in the second half, but 196 of those rushing yards were gained in the first two quarters. So the Tigers' defense certainly has some things to clean up ahead of next week. Clemson, however, did outgain The Citadel, 302-288, on the ground. Hamilton: Bad refs marring an otherwise awesome football season With all of those rushing yards, The Citadel actually led the Tigers in total yardage a minute and a half into the second quarter, 122-78. A missed field goal, and Page's pick-6, negated a couple of drives that drove deep into Clemson territory But the Tigers' offense would do its best to make sure they remained frontrunners against an FCS team. Clemson scored touchdowns on its first five drives, including a 55-yard bomb from Klubnik to Wesco that put Clemson ahead in the yardage total and made it a 21-0 game. Now, Clemson turns its attention to one of the most-anticipated South Carolina games in recent memory. The Gamecocks, which played Wofford this weekend, heads into the regular-season finale with an 8-3 record. Clemson will be 9-2 and looking to notch its first ranked win of the season. There are no ACC title game implications — the Tigers need Miami to lose at Syracuse to make that a possibility — but there is a very outside chance that Clemson could use an SEC resume-booster for an at-large bid in the playoff. If nothing else, the Tigers will want to defend home field after allowing South Carolina to win the matchup in Death Valley in 2022.

The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.

Owaisi slams religious surveys, accuses govt of targetting waqf properties

None